Organ and Tissue Transplantation Market: by Product (Immunosuppressants, Preservation Solutions, and Tissue Products), By Application (Organ Transplantation (Heart, Lungs, Liver, Kidney, Intestine/Small Bowel, Pancreas), Tissue Transplantation (Skin Transplantation, Cellular Transplantation, Cornea, Vascular Transplantation, Bone Graft Transplantation)), By End User (Hospitals, Transplantation Centers, Others), and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)  

Purchase Option

$ 4400
$ 6600
$ 8900

The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2023 to 2029. Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient's body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure. The organ and tissue transplantation market is also being boosted by the launch of technologically improved products and an increase in the number of tissue banks. However, several limitations, such as a scarcity of organ donors for transplantation, are projected to limit market expansion. The demand for organs for organ failure treatment is far greater than the supply, which can be linked to a variety of religious and traditional views, as well as a lack of awareness regarding organ donation. During the projection period, the immunosuppressive medications segment is expected to grow at the fastest rate. This is due to the widespread use of these medications to prevent tissue or organ rejection after transplantation. Organ replacements are becoming more popular as the prevalence of chronic diseases rises. As a result, demand for immunosuppressive medications is likely to surge during the predicted period.

Organ And Tissue Transplantation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.7%

Largest Market

North America

Fastest Growing Market

Europe
Organ and Tissue Transplantation Market Dynamics

Increase in the prevalence of chronic diseases and rising organ and tissue transplantation owing to organ damage or impairment is the key factor driving the growth of the market. The improving technology for organ and tissue transportation and transplantation is adding fuel for the growth of the market. The increasing investments in the research and development is providing opportunity for the growth of the market. However, the increasing incidence of the organ failures post-surgery is hampering the growth of the market. The limited number of donors is also and high cost involved in the treatment is expected to restrain the growth of the market. Lack of awareness regarding organ donation is likely to constrain the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Organ And Tissue Transplantation Market Segmentation

By Product Type
  • Immunosuppressants
  • Preservation Solutions
  • Tissue Products
By Application
  • Organ Transplantation
    • Heart
    • Lungs
    • Liver
    • Kidney
    • Intestine/Small Bowel
    • Pancreas
  • Tissue Transplantation
    • Skin Transplantation
    • Cellular Transplantation
    • Cornea
    • Vascular Transplantation
    • Bone Graft Transplantation
By End User
  • Hospitals
  • Transplantation Centers
  • Others

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2023 to 2029.

1.Executive Summary
2.Global Organ and Tissue Transplantation Market Introduction 
2.1.Global Organ and Tissue Transplantation Market  - Taxonomy
2.2.Global Organ and Tissue Transplantation Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Organ and Tissue Transplantation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Organ and Tissue Transplantation Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Organ and Tissue Transplantation Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Immunosuppressants
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Preservation Solutions
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Tissue Products
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Organ and Tissue Transplantation Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Organ Transplantation
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Tissue Transplantation
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Organ and Tissue Transplantation Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Transplantation Centers
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Organ and Tissue Transplantation Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Immunosuppressants
9.1.2.Preservation Solutions
9.1.3.Tissue Products
9.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Organ Transplantation
9.2.2.Tissue Transplantation
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Transplantation Centers
9.3.3.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Immunosuppressants
10.1.2.Preservation Solutions
10.1.3.Tissue Products
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Organ Transplantation
10.2.2.Tissue Transplantation
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Transplantation Centers
10.3.3.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Immunosuppressants
11.1.2.Preservation Solutions
11.1.3.Tissue Products
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Organ Transplantation
11.2.2.Tissue Transplantation
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Transplantation Centers
11.3.3.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Immunosuppressants
12.1.2.Preservation Solutions
12.1.3.Tissue Products
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Organ Transplantation
12.2.2.Tissue Transplantation
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Transplantation Centers
12.3.3.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Immunosuppressants
13.1.2.Preservation Solutions
13.1.3.Tissue Products
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Organ Transplantation
13.2.2.Tissue Transplantation
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Transplantation Centers
13.3.3.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Hoffmann-La Roche Ltd. (Switzerland)
14.2.2.Novartis International AG (Switzerland)
14.2.3.OrganOX Limited (UK)
14.2.4.Terumo Medical Corporation (US)
14.2.5.Transonic (US)
14.2.6.Bio Med Pvt. Ltd. (US)
14.2.7.Transplant Biomedical (UK)
14.2.8.GlaxoSmithKline Plc. (UK)
14.2.9.Accord Healthcare GmbH (Spain)
14.2.10.Sanofi (France)
14.2.11.Pfizer, Inc. (US)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis International AG (Switzerland)
  • OrganOX Limited (UK)
  • Terumo Medical Corporation (US)
  • Transonic (US)
  • Bio Med Pvt. Ltd. (US)
  • Transplant Biomedical (UK)
  • GlaxoSmithKline Plc. (UK)
  • Accord Healthcare GmbH (Spain)
  • Sanofi (France)
  • Pfizer, Inc. (US)

Adjacent Markets